Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease
about
Disruption of Myosin 1e promotes podocyte injuryThe effect of progressive glomerular disease on megalin-mediated endocytosis in the kidneyComparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.No evidence for statin-induced proteinuria in healthy volunteers as assessed by proteomic analysis.Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosisComplement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury.Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy.Diabetic albuminuria is due to a small fraction of nephrons distinguished by albumin-stained tubules and glomerular adhesions.Complement activation in progressive renal disease.Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria.High (≥6.5) Spontaneous and Persistent Urinary pH Is Protective of Renal Function at Baseline and during Disease Course in Idiopathic Membranous Nephropathy.
P2860
Q28509726-334DBE6C-3BFD-4025-9A1C-50BBF1F507BEQ34021381-78F72D6D-AC5A-46CF-B232-6C4C1C2B1AB4Q34380070-F521CFA0-46C1-4533-B61D-84912A70BA06Q35210176-8EB9697E-0DA2-452D-9655-F55EBDA55936Q35748159-2C6094D4-FC33-4B4F-88AA-67ED0CC155EFQ36677636-B20AFF8F-6D97-4A6A-BC5B-4243B0725730Q36949212-2DF85E3B-ACB3-461D-82EB-497A128DE0A3Q37278421-CDD80DC1-3830-4951-8D45-C0530D8362DFQ38348940-0B5876D1-5B84-410F-A853-05945CF74BD3Q38639083-1C36C732-D775-489B-85CA-4AA3CAAE115EQ38936622-BFE69E22-C851-437D-804E-7A000698FD55Q41279888-95CB585A-BFE0-48CE-8685-9C31C5B080FEQ41464088-8A61B36F-C240-4FA5-9E4A-F06E6AE044BA
P2860
Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease
description
scientific article published on 01 April 1999
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 1999
@uk
name
Antiproteinuric therapy while ...... in experimental renal disease
@en
Antiproteinuric therapy while ...... in experimental renal disease
@nl
type
label
Antiproteinuric therapy while ...... in experimental renal disease
@en
Antiproteinuric therapy while ...... in experimental renal disease
@nl
prefLabel
Antiproteinuric therapy while ...... in experimental renal disease
@en
Antiproteinuric therapy while ...... in experimental renal disease
@nl
P2093
P1476
Antiproteinuric therapy while ...... in experimental renal disease
@en
P2093
P304
P407
P577
1999-04-01T00:00:00Z